Eiger BioPharmaceuticals, Inc.
|
-71.03 Million USD
|
89.366%
|
Nanobac Pharmaceuticals, Incorporated
|
-5.92 Million USD
|
-27.404%
|
SQZ Biotechnologies Company
|
-64.14 Million USD
|
88.223%
|
Evofem Biosciences, Inc.
|
-17.37 Million USD
|
56.513%
|
Santhera Pharmaceuticals Holding AG
|
94.03 Million USD
|
108.033%
|
Mesoblast Limited
|
-62.38 Million USD
|
87.893%
|
Propanc Biopharma, Inc.
|
-1.53 Million USD
|
-391.758%
|
Genus plc
|
73.7 Million USD
|
110.249%
|
VioQuest Pharmaceuticals, Inc.
|
-6.61 Million USD
|
-14.25%
|
CNBX Pharmaceuticals Inc.
|
-3.54 Million USD
|
-112.959%
|
Marizyme, Inc.
|
-34.28 Million USD
|
77.966%
|
ContraFect Corporation
|
-64.99 Million USD
|
88.379%
|
Nymox Pharmaceutical Corporation
|
-8.77 Million USD
|
13.889%
|
PsyBio Therapeutics Corp.
|
-4.52 Million USD
|
-66.887%
|
Sienna Biopharmaceuticals, Inc.
|
- USD
|
Infinity%
|
RegeneRx Biopharmaceuticals, Inc.
|
-1.4 Million USD
|
-438.85%
|
Intellipharmaceutics International Inc.
|
-2.64 Million USD
|
-185.642%
|
AXIM Biotechnologies, Inc.
|
-2.32 Million USD
|
-225.053%
|
MultiCell Technologies, Inc.
|
-518.04 Thousand USD
|
-1358.103%
|
Accustem Sciences Inc.
|
-3.74 Million USD
|
-101.623%
|
RVL Pharmaceuticals plc
|
-48.22 Million USD
|
84.337%
|
EV Biologics, Inc.
|
-1.26 Million USD
|
-496.121%
|
Q BioMed Inc.
|
-617.62 Thousand USD
|
-1123.009%
|
Emmaus Life Sciences, Inc.
|
3.57 Million USD
|
311.468%
|
Neon Bloom, Inc.
|
-632.4 Thousand USD
|
-1094.43%
|
Mosaic ImmunoEngineering Inc.
|
-2.28 Million USD
|
-230.649%
|
Biomind Labs Inc.
|
-1.03 Million USD
|
-630.139%
|
TetraLogic Pharmaceuticals Corporation
|
- USD
|
Infinity%
|
Pharming Group N.V.
|
9.87 Million USD
|
176.477%
|
Oncotelic Therapeutics, Inc.
|
-7.16 Million USD
|
-5.479%
|
Skye Bioscience, Inc.
|
-13.54 Million USD
|
44.243%
|
Therapeutic Solutions International, Inc.
|
-1.48 Million USD
|
-407.838%
|
THC Farmaceuticals, Inc.
|
-25 Thousand USD
|
-30114.58%
|
Arch Therapeutics, Inc.
|
-3.88 Million USD
|
-94.465%
|
IMV Inc.
|
-35.52 Million USD
|
78.736%
|
Acro Biomedical Co., Ltd.
|
-15.86 Million USD
|
52.402%
|
Curative Biotechnology, Inc.
|
-2.5 Million USD
|
-201.909%
|
GB Sciences, Inc.
|
-1.41 Million USD
|
-431.99%
|
Alpha Cognition Inc.
|
-9.7 Million USD
|
22.172%
|
HST Global, Inc.
|
-5303.00 USD
|
-142340.977%
|
CSL Limited
|
4.78 Billion USD
|
100.158%
|
Halberd Corporation
|
-74.27 Thousand USD
|
-10069.287%
|
Enzolytics Inc.
|
-2.12 Million USD
|
-255.963%
|
Resverlogix Corp.
|
-11.74 Million USD
|
35.67%
|
Affymax, Inc.
|
-14.29 Million USD
|
47.159%
|
SYBLEU INC
|
-141.57 Thousand USD
|
-5235.588%
|
Nuo Therapeutics, Inc.
|
-3.06 Million USD
|
-146.608%
|
argenx SE
|
-216.02 Million USD
|
96.503%
|
MetaStat, Inc.
|
- USD
|
Infinity%
|
Northwest Biotherapeutics, Inc.
|
-55.33 Million USD
|
86.35%
|
Enzon Pharmaceuticals, Inc.
|
1.21 Million USD
|
720.677%
|
Arno Therapeutics, Inc.
|
- USD
|
Infinity%
|
RespireRx Pharmaceuticals Inc.
|
-1.49 Million USD
|
-403.944%
|
GeneThera, Inc.
|
- USD
|
Infinity%
|
Inhibitor Therapeutics, Inc.
|
378.84 Thousand USD
|
2093.867%
|
AVAX Technologies, Inc.
|
-6.11 Million USD
|
-23.574%
|
Zenith Capital Corp.
|
-8.6 Million USD
|
12.228%
|
Genscript Biotech Corporation
|
-248.71 Million USD
|
96.963%
|
Ember Therapeutics, Inc.
|
-17.42 Thousand USD
|
-43259.423%
|
Anthera Pharmaceuticals, Inc.
|
- USD
|
Infinity%
|
Sigyn Therapeutics, Inc.
|
-2.44 Million USD
|
-208.758%
|
WPD Pharmaceuticals Inc.
|
-176.02 Thousand USD
|
-4191.25%
|
American Oriental Bioengineering, Inc.
|
-39.63 Million USD
|
80.943%
|
Provectus Biopharmaceuticals, Inc.
|
-2.89 Million USD
|
-161.162%
|
Adynxx, Inc.
|
- USD
|
Infinity%
|
Helix BioMedix, Inc.
|
-1.04 Million USD
|
-621.93%
|
GlobeStar Therapeutics Corporation
|
6724.00 USD
|
112438.563%
|
VitaSpring Biomedical Co. Ltd.
|
- USD
|
Infinity%
|
Capstone Therapeutics Corp.
|
-1.74 Million USD
|
-331.637%
|
Cotinga Pharmaceuticals Inc.
|
-1.92 Million USD
|
-293.232%
|
ONE Bio Corp.
|
13.61 Million USD
|
155.488%
|
Reve Technologies, Inc.
|
-181.08 Thousand USD
|
-4071.257%
|
Burzynski Research Institute, Inc.
|
- USD
|
Infinity%
|
Wesana Health Holdings Inc.
|
-2.05 Million USD
|
-267.217%
|
Agentix Corp.
|
-1.37 Million USD
|
-450.655%
|
LadRx Corporation
|
412.28 Thousand USD
|
1932.15%
|
Cell Source, Inc.
|
-4.27 Million USD
|
-76.796%
|
ProtoKinetix, Incorporated
|
-367.22 Thousand USD
|
-1956.975%
|
Regen BioPharma, Inc.
|
1.46 Million USD
|
615.271%
|
Regen BioPharma, Inc.
|
-936.94 Thousand USD
|
-706.196%
|
NovAccess Global Inc.
|
-1.03 Million USD
|
-629.964%
|
Endonovo Therapeutics, Inc.
|
8.85 Million USD
|
185.315%
|
Itoco Inc.
|
-1.86 Million USD
|
-304.155%
|
Rasna Therapeutics, Inc.
|
-379.62 Thousand USD
|
-1889.791%
|
Pathfinder Cell Therapy, Inc.
|
-1.11 Million USD
|
-576.85%
|
Kadimastem Ltd
|
-2.62 Million USD
|
-187.826%
|
Oncology Pharma Inc.
|
- USD
|
Infinity%
|
Institute of Biomedical Research Corp.
|
-239.15 Thousand USD
|
-3058.539%
|
CytoDyn Inc.
|
-18.02 Million USD
|
58.103%
|
Claritas Pharmaceuticals, Inc.
|
- USD
|
Infinity%
|
NDT Pharmaceuticals Inc.
|
-79.02 Thousand USD
|
-9458.067%
|
Mobile Lads Corp.
|
-2.24 Million USD
|
-237.042%
|
NanoSphere Health Sciences Inc.
|
-12.22 Thousand USD
|
-61668.297%
|
Qrons Inc.
|
-40.08 Thousand USD
|
-18745.949%
|
Alseres Pharmaceuticals, Inc.
|
-485.67 Thousand USD
|
-1455.278%
|
Advanced Proteome Therapeutics Corporation
|
- USD
|
Infinity%
|
Nascent Biotech, Inc.
|
527.43 Thousand USD
|
1532.153%
|
Rebus Holdings, Inc.
|
-951 Thousand USD
|
-694.284%
|
ImmunoCellular Therapeutics, Ltd.
|
-1.06 Million USD
|
-611.259%
|
International Stem Cell Corporation
|
202 Thousand USD
|
3839.428%
|
Bioxytran, Inc.
|
-3.82 Million USD
|
-97.732%
|
GlobeImmune, Inc.
|
- USD
|
Infinity%
|
Predictive Technology Group, Inc.
|
- USD
|
Infinity%
|
ProText Mobility, Inc.
|
-52.64 Thousand USD
|
-14249.63%
|
Cardax, Inc.
|
- USD
|
Infinity%
|
VG Life Sciences Inc.
|
-2.46 Million USD
|
-206.818%
|
Kaleido Biosciences, Inc.
|
- USD
|
Infinity%
|
Advaxis, Inc.
|
-35.86 Million USD
|
78.941%
|
Adhera Therapeutics, Inc.
|
- USD
|
Infinity%
|
RenovaCare, Inc.
|
- USD
|
Infinity%
|
Regnum Corp.
|
-45 Thousand USD
|
-16685.878%
|
Innovation Pharmaceuticals Inc.
|
-2.73 Million USD
|
-175.882%
|
Neutra Corp.
|
-181.24 Thousand USD
|
-4067.597%
|
Windtree Therapeutics, Inc.
|
-20.15 Million USD
|
62.53%
|
PureTech Health plc
|
-11.62 Million USD
|
35.034%
|
Coeptis Therapeutics, Inc.
|
-20.15 Million USD
|
62.527%
|
IXICO plc
|
-707 Thousand USD
|
-968.408%
|
IntelGenx Technologies Corp.
|
-7.68 Million USD
|
1.709%
|
Gelesis Holdings, Inc.
|
-48.34 Million USD
|
84.376%
|
CSL Limited
|
4.73 Billion USD
|
100.16%
|
Cellectis S.A.
|
-92.63 Million USD
|
91.846%
|